Delivery Order SPE2DB24D2205-SPE2DB25FEFZW
- Not listed
- The Defense Logistics Agency awarded a $1,291.54 delivery order to AmerisourceBergen Drug Corp on July 23, 2025, for the supply of Epinephrine 0.3 mg auto-injector pens (2-pack). This firm fixed-price delivery order, with an ultimate completion date of July 24, 2025, represents a pediatric and emergency medical supply critical for military and federal healthcare systems. The contract was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate...
- The Defense Logistics Agency awarded a delivery order valued at $1,590.55 to AmerisourceBergen Drug Corp for the supply of Epinephrine 0.3 mg auto-injector pens (2-packs) on August 5, 2025, with completion scheduled for August 6, 2025. This firm fixed-price contract, which carries no set-aside designation, was competitively awarded and will be performed at the contractor's Conshohocken, Pennsylvania facility. The delivery order represents a small-value transaction under AmerisourceBergen Drug...
- The Defense Logistics Agency awarded a $1,413.12 delivery order to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of Epinephrine 0.15 mg auto-injectors (2-pack). This firm fixed-price contract, with an ultimate completion date of August 6, 2025, represents a child order under AmerisourceBergen's larger pharmaceutical supply agreement with DLA. The award was competitively made with no set-aside designation, and performance will occur at the contractor's Conshohocken, Pennsylvania...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $5,996.40 for epinephrine 0.3 mg auto-injector (2-pack) on July 31, 2025, with completion targeted for August 1, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The contract represents a critical pharmaceutical supply need within the federal medical...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order valued at $1,082.90 to AmerisourceBergen Drug Corp for the supply of Epinephrine 0.3 mg auto-injectors (2-pack) on August 8, 2025, with completion scheduled for August 11, 2025. The contract is a firm fixed-price delivery order with no set-aside designation, competitively awarded to the major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania. This award represents a small-value transaction typical of...
- The Defense Logistics Agency awarded a $23,377.86 firm fixed price delivery order to AmerisourceBergen Drug Corp for the supply of Epinephrine 0.3 mg auto-injector (2-pack) on July 23, 2025, with completion targeted for July 24, 2025. This competitively awarded, non-set-aside contract is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a single transaction under AmerisourceBergen's larger pharmaceutical supply relationship...
- The Defense Logistics Agency awarded a $2,273.25 delivery order to AmerisourceBergen Drug Corp for the supply of Epinephrine 0.3 mg auto-injector (2-pack) on July 18, 2025, with completion scheduled for July 21, 2025. This competitively awarded, firm fixed-price contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The place of performance is located in...
- The Defense Logistics Agency awarded a delivery order valued at $1,562.10 to AmerisourceBergen Drug Corp for Epinephrine 0.3 mg auto-injector two-packs, with a completion date of July 30, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a child order under AmerisourceBergen's larger pharmaceutical supply agreement with DLA. The product will be performed at the company's corporate headquarters location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a delivery order valued at $17,703.31 to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of Epinephrine 0.3 mg auto-injector (2-pack). This competitively awarded, firm fixed-price contract represents a non-set-aside procurement with an ultimate completion date of August 6, 2025. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters and primary...
- The Defense Logistics Agency awarded a delivery order valued at $1,856.40 to AmerisourceBergen Drug Corp for the supply of epinephrine 0.3 mg auto-injector units (2-pack). This non-set-aside, competitively awarded contract utilizes firm fixed pricing and was executed on August 9, 2025, with an ultimate completion date of August 11, 2025. The pharmaceutical products will be performed at AmerisourceBergen's corporate headquarters location in Conshohocken, Pennsylvania. This delivery order falls...
- SPE2DB24D2205Indefinite Delivery Contract
- SPE2DB24D2205-SPE2DB25FEFZWDelivery Order
The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,040.97 for epinephrine 0.3 mg auto-injector pens (two-pack) on August 8, 2025, with completion scheduled for August 11, 2025. This competitively awarded, firm fixed-price contract represents a pediatric or emergency medical supply procurement supporting federal healthcare systems. The contract is not set-aside and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. This comprehensive global pharmaceutical support vehicle enables AmerisourceBergen to supply a broad range of pharmaceutical products and medical commodities to support military healthcare programs worldwide. The company serves as a critical federal vendor for the Defense Health Agency and other government healthcare systems, with demonstrated capability to fulfill diverse medical procurement requirements through multiple therapeutic domains and product categories.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.0k | 8/8/25 |